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Clinical (1) and experimental (2) analyses of transformation indicate that two
or more alterations of normal cell function are required to induce autonomous
growth of malignant cells. In many instances, one of these events appears to be
associated with deregulated expression ofa protooncogene . Studies ofmurine B
lineage neoplasms have shown that a variety of oncogenes, including abl (3), fes,
Ha-ras, Ki-ras, bas, src (4), myc (5), erbB (7) and the transforming gene carried
by Cas NS-1 (8), can contribute to induction oftumors of this lineage . In contrast,
little is known about the postulated second events that participate in the devel-
opment of these neoplasms. Recently, it was found that pre-B cell tumors, but
not fibroblasts transformed by the abl-containing Abelson murine leukemia virus
(A-MuLV) regularly express high levels of a cell surface glycoprotein of 160 kD
(gp160611) that is not a product of genes in the A-MuLV complex (9, 10);
gp1606cs contains an epitope detected by the monoclonal antibody 6C3 . Al-
though this antigen is expressed at low levels on some normal thymocytes and
bone marrow cells (10), these cells appear to acquire the molecule by transfer
from stromal elements, whereas the molecule is actively synthesized by trans-
formed hematopoietic cell lines (10) . The observation that expression of the 6C3
antigen appears after A-MuLV-infected cells become independent of feeder
layers for growth in vitro suggests that activation of the gene encoding this
molecule is associated with acquisition of the fully transformed phenotype . If this
suggestion is correct, this gene could be considered an oncogene with the
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potential for complementing abl and possibly other oncogenes to induce trans-
formation of a variety of cell types.
In this study we undertook an examination of a large series of hematopoietic
tumors for the presence of the 6C3 antigen, gp1606cs was found on most B-
lineage spontaneous tumors and each B-lineage tumors induced by replication-
defective MuLV containing the oncogenesfes, abl, H-ras, bas, src, erbB, and Cas
NS-1, but not on T cell lymphomas, or myelomonocytic leukemias or erytholeu-
kemias. By comparison, none of the early B-lineage lymphomas induced by v-myc
or involving translocated c-myc sequences bear the antigen.
Materials and Methods
Cells.
￿
Cell lines containing abl, fes, ras (including Ha-ras, Ki-ras, and bas), srcand erbB
were produced by infection of fetal liver or bone marrow cells in vitro with Moloney or
4070A pseudotypes, or with replication-defective viruses, as described (4). Cell lines
induced by Friend spleen focus-forming virus (F-SFFV) and Cas NS-1 were adapted to
growth in vitro from primary tumors or passaged in vivo. Five in vitro-adapted cell lines
from A-MuLV plasmacytoid lymphosarcoma (ABPL) tumors with 5'-truncated mybgenes
have been shown to be of myelomonocytic origin (G. L. C. Shen-Ong, K. L. Holmes, H.
C. Morse, III, manuscript submitted for publication). One IL-3-dependent cell line with
a 3'-truncated myb gene and myeloid characteristics has been described (15).
Viruses.
￿
Virologic characteristics of CWD/Agl (12), Bio.NZN (13), and NFS.Akv-1
(14) mice are published. Data concerning the structure and transforming activities ofJ-3,
J-5, J-2, andJ-1 recombinant viruses are presented elsewhere (6). Northern blot hybridi-
zation studies of mRNA produced by Cas NS-I-transformed pre-B cells indicate that the
Cas NS-1 transforming gene is unrelated to abl, myc, myb, Ki-ras, mos, fos, raf, erbB,fms,
sis, Pim-1, src, p53, ets, fes, or bcl-2 (11).
Characterization of Tumors.
￿
All the tumors were characterized as to cell lineage and
state of differentiation by flow microfluorometry (FMF) studies using a large panel of
antibodies to cell surface antigens (4, 8). Gross and histological studies were carried out
on tissues obtained at autopsy from mice .
Polyacrylamide Gel Electrophoresis. Immunoprecipitation and SDS-PAGE have been
described before (9).
Results
To determine if expression of gp1606cs is limited predominantly to pre-B cells
induced by A-MuLV, we analyzed a large series of hematopoietic tumors for
expression of this antigen (Table I). All the tumors diagnosedas T cell lymphomas
were Thy-1+ and variably expressed Ly-1, Ly-2, L3T4, or Tla. Pre-B cell
lymphomas were all surface immunoglobulin (slg)-negative and Lyb-2', and
consisted mostly of large pre-B cell tumors. The B cell lymphomas were uniformly
sIg' and all plasmacytomas were PC-1+. The diagnosis of erythroleukemia was
made primarily on histologic grounds, as these tumors are predominantly null
for the antibodies used in the FMF studies (8). Finally, all the myelomonocytic
tumors were Mac-1+, Ly-17+ (alleles of Ly-17 define polymorphisms of the Fc-y-
R) and most were la'. Studies of these tumors for expression of the 6C3 antigen
showed that, with one exception, only tumors of the B lymphocyte lineage were
6C3+. Thus, 53 of 59 (90%) pre-B cell lymphomas and 15 of 31 (48%) B cell
lymphomas were 6C3+, whereas none of the 44 T cell lymphomas or 11
erythroleukemias expressed this antigen (Table I). The only one of 13 myelo-
monocytic tumors found to be 6C3+ was the macrophage cell line, P388D1 . This922
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TABLE I
Expression of 6C3 Antigen on Hematopoietic Tumor Cells
Figures indicate the number of6C3* tumors (T, T cell lymphoma; pre-B, pre-B cell lymphoma; B, B cell lymphoma;
PCT, plasmacytoma) over the total number oftumors examined.
apparent discrepancy may be explained by the recent finding that this tumor has
many characteristics of cells in the B lymphocyte lineage, including expression
of Lyb-2 and Ly-5 (13220), and rearrangements of Ig heavy and light chain genes
(16).
Almost all of the pre-B cell lymphomas induced by retroviruses containing the
Cas NS-1 transforming gene, abl, ras (including H-ras, Ki-ras, and bas), fes, src,
or erbB were 6C3+. By comparison, none of 20 pre-B, B cell, or plasmacytic
tumors induced by viruses expressing v-myc were positive for this antigen (Table
I). In addition, more than 10 pre-B lymphomas of mice transgenic for c-myc
driven by Ig enhancer sequences (17) have been examined, and none express
6C3 antigen (W. Y. Langdon, A. W. Harris,J. M. Adams, and S. Cory, personal
communication). It is known that ^-60% of these tumors have pre-B cell charac-
teristics (17). This indication that deregulated expression of myc is incompatible
with high levels of 6C3 expression is supported indirectly by two findings: First,
the c-myc genes of all seven 6C3+ pre-B and B cell lymphoma cell lines included
Virus Transduced
oncogene T Pre-B
Frequency
B
of6C3* tumors
PCT Erythroid Myelo-
monocytic
A. Virus-induced primary tumors
Cas NS-1 Cas NS-1 12/13
Abelson abl 3/3 1/1
J-3 myc 0/4 0/1 0/3 0/10 0/5
J-5 MY 0/9 0/1 0/1
J-2 raf + myc 0/4 0/6 0/5
J-1 raf 0/5
Moloney - 0/9
Cas NS-6 - 0/8 1/1 0/1
SL3-3 - 0/5
Gross passage A - 0/1
C2S - 0/2
B. Primary spontaneous tumors ofhigh-virus mice
CWD - 0/1 1/1 10/14
B10.NZW - 1/1
NFS.Akv-1 - 0/1
C. Cell lines induced by viruses containing oncogenes or pristane-induced PCT
abl 7/7 1/1
ras 7/9
fes 3/3
src 6/6
erbB 5/5
myc 0/3
Cas NS-1 1/1
F-SFFV 0/1
myb 0/6
D. Cell lines with no oncogene defined
7/8 2/4 1/1
Total: 0/44 53/59 15/31 0/13 0/11 1/13MORSE ET AL .
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FIGURE 1 .
￿
Cells from the Cas NS-1-induced pre-B cell lymphoma, NFS-467 (lanes I and 2),
and the Abelson virus-induced pre-B cell lymphoma LI-2/23 (lanes 3 and 4) were surface
labeled with 1251 using lactoperoxidase (9), lysed, and reacted with mAb 6C3 (lanes 2 and 3)
(9, 10), or isotype-matched (rat IgG2a) mAb R7D4 (10). The immune complexes were
precipitated with goat anti-rat Ig and analyzed by SDS-PAGE (8% gel) under reducing
conditions (10) .
in Table I D are not rearranged and these cells contain c-myc transcripts at levels
consistent with their stages of differentiation (11 ;J . F . Mushinski,W . F . Davidson,
H . C . Morse Ill, unpublished observations) . Second, three plasmacytomas with
translocated c-myc loci and elevated myc RNAs were 6C3- .
Comparisons of "'I-labeled cell surface proteins precipitated from a pre-B cell
lymphoma (NFS-46'7) induced by the Cas NS-1 transforming virus and a pre-B
cell lymphoma (L1-2) induced by A-MuLV showed that the predominant proteins
reactive with 6C3 were of 159 and 160 kD, respectively (Fig . 1) . It is likely that
the 6C3-reactive antigens present on cells transformed by A-MuLV and other
replication-defective or -competent viruses are very similar, with molecular mass
differences possibly reflecting variations in glycosylation of a common protein .
Discussion
These results demonstrate that expression of gpI60scs antigen is often associ-
ated with neoplastic transformation ofearlyB lymphocytes . These results support
by tumor cells is confined to
age (9) . Additionally, we present evidence here that the 6C3 antigen is
expressed in early B leukemias that have been induced with a variety of "cyto-
plasmic", oncogenes but never with the "nuclear" myc oncogene . These findings
suggest that alternative 6C3+ and 6C3- pathways may be involved in the trans-
formation of B lineage cells with otherwise indistinguishable phenotypes . There
is no evidence to suggest that mAb 6C3 defines leukemias of a B sublineage
distinct from a sublineage transformed by myc .924
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If the assumption is made that transformation of normal B lineage cells, like
otherprimary cells (2), requires the interaction ofat least two kindsofoncogene
products (nuclear and cytoplasmic), there are several possible models for
coexpression of the 6C3 antigen with a cytoplasmic but not a nuclear oncogene.
For example, functions provided to normal cells by the gene encoding the 6C3
antigen may be similar to those provided by myc. The observation that this
antigen is expressed on the surface of tumor cells is not incompatible with the
suggestion that its location in normal cells is nuclear, but that like the simian
virus 40 large T antigen, both nuclear and surface membrane functions can
contribute to the immortalization and transformation of cells (18). In a second
model, aberrant expression of gp1606cs on the cell surface may drive the
expression ofa nuclear oncogene that can complement the different cytoplasmic
viral oncogenes for transformation of B lineage cells. In either model, the
provision ofa nuclear signal via deregulated myc expression would preclude the
requirement to engage either the nuclear or surface membrane functions pos-
tulated for the 6C3 antigen. In a third model, different cytoplasmic oncogenes
may indirectly induce or augment expression ofthe gene encoding gp1606C3 in
a way unrelated to any contribution of the antigen to the induction or mainte-
nance of the transformed phenotype. While several other models are also
possible, each of the above leads to a specific, testable prediction.
Summary
The monoclonal antibody 6C3 was used to test a wide variety of murine
hematopoietic neoplasms for cell surface expression of a 160 kD glycoprotein
(gp1606c3) previously shown to be expressed by neoplastic pre-B and some B
lymphocytes transformed by Abelson murine leukemia virus (A-MuLV). This
antigen was expressed on many pre-B and B cell lymphomas, but not on A-
MuLV-transformed fibroblasts, T cell lymphomas, ormyelomonocytic leukemias.
gp1606cs was expressed by most early B-lineage spontaneous tumors, and early
B tumors induced by replication-defective MuLV-containing oncogenes the
products of which are associated with the cytoplasmic aspect of the plasma
membrane, i.e.,fes, abl, H-ras, bas, src, erbB, and Cas NS-1. By comparison, none
of the early B lineage lymphomas induced by the "nuclear" oncogene avian v-
myc MuLV, or arising in mice transgenic for a murine c-myc gene, or later B cell
lineage stages bearing translocations of the c-myc locus expressed this antigen.
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